FG001 clinical trials

An open-label, non-randomized, single dose, phase II trial of FG001 (an optical imaging agent) for localization of Meningiomas or presumed Low- Grade Gliomas scheduled for neurosurgery.

Doctors are testing a new special dye called FG001 to help them see brain tumours like meningiomas and low-grade gliomas better during surgery. This study checks if the dye helps spot all the tumour tissue accurately and if it's safe for patients.